One of the most commonly used pharmaceutical manufacturing processes is granulation. Granulation is extensively used in the manufacturing of tablets or capsules which are most common ways in which therapeutic molecules are administered to patients. It is therefore not surprising that most efforts at developing continuous processes have been aimed at granulation.
This webinar will focus on the following topics:
- Shortcomings associated with the current batch manufacturing processes
- Advantages of continuous processing in general
- Limitations observed in continuous processors today
- Introduction to true continuous granulation technologies and the associated advantages
- STEERLife’s proprietary Continuous Activated Granulation technologies – continuous wet granulation, moisture and shear activated dry granulation and melt granulation
- Case studies.
Dr. Babu Padmanabhan, Managing Director and Chief Knowledge Officer, STEERLife
Dr. Babu’s journey began with a vision — to steer a new world. He has made significant contributions to the field of polymer processing. His work in designing processing section components has led to the development of intelligent compounding technology that has redefined Pharmaceutical manufacturing. The fractional lobed processor (FLP) invented by him provides critical breakthrough in continuous granulation.
Mr. Indu Bhushan, Chief Technical Officer, STEERLife
Mr.Indu Bhushan, brings more than 2 decades of core Pharmaceutical development experience to the table. With his contribution to more than 20 publications and patents, his current research activities in STEERLife focus on creating a difference to the way Pharmaceuticals are manufactured and administered. Prior to STEERLife, he was associated with several leading multinational companies where he played a key role in setting up the facilities and resources for the development of generic and specialty Pharmaceuticals.
Who Should Attend?
Senior level executives from Pharmaceutical & Biotechnology companies, CROs and Government Institutions:
- Head of Regulatory Affairs
- Process Managers
- Research Scientists & Developers
STEERLife, a unique and seamless blend of engineering and Pharmaceutical expertise, is committed to the design and creation of advanced technologies capable of changing the way the world makes and takes medicines. Their proprietary technologies such as novel hot melt extrusion, hot melt fragmentation and activated granulation help manufacturers move from batch to true continuous processing and thereby from Quality by Testing to Quality by Design. Besides, they also help create delivery systems that change the way medicines are taken. STEERLife can provide customised technology solutions, licensing opportunities, lifecycle management solutions and the manufacture of differentiated products to its partners.
For more information visit: steerlife.com